showed a nonsignificant trend towards improved overall survival for adjuvant therapy (radiotherapy, chemotherapy, or both) in comparison to surgery without adjuvant therapy for patients with biliary tract cancers, including GBC (odds ratio [OR] 0.74; 95% CI, 0.55–1.01; p = 0.06) [ 86 ].
1
—
—